Clinical Trial

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis and the prevention of secondary bladder shrinkage with a decrease in its volume.
Trial Details
NCT Number NCT07391306
Lead Sponsor JSC NextGen
Conditions IC, Interstitial Cystitis and Bladder Pain Syndrome, Interstitial Cystitis, Chronic
Enrollment 180 participants
Start Date 2024-02-16
Primary Completion 2027-05-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-05